Attitudes of Canadian nephrologists toward dialysis modality selection

Peritoneal Dialysis International

Volumn 19, Issue 3, 1999, Pages 263-268

  Jung, Beverly ^a   Blake, Peter G ^b   Mehta, Ravindra L ^c   Mendelssohn, David C ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Dialysis modalities; End stage renal disease; Esrd; Hemodialysis; Survey

Indexed keywords

ARTICLE; CANADA; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; COST EFFECTIVENESS ANALYSIS; HEMODIALYSIS; HOME DIALYSIS; HUMAN; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; NEPHROLOGY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REIMBURSEMENT;

EID: 0033395813     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089901900313     Document Type: Article

References (21)

1. Kiberd BA. Equitable allocation versus best outcome: competing economic and ethical strategies in renal transplantation. Ann R Coll Surg Can 1992; 25:446-8.
2. Fenton SSA, Schaubel D, Desmeules M, Morrison H, Mao Y, Copleston P, et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30:334-42.
3. Maiorca R, Cancarini GC, Zubani R, Camerini C, Manili L, Brunori G, et al. CAPD Viability: a long term comparison with hemodialysis. Perit Dial Int 1996; 16:276-87.
4. Held PJ, Port FK, Turenne MN, Gaylin DS, Hamburger RJ, Wolfe RA. Continuous ambulatory peritoneal dialysis and hemodialysis: comparison of patient mortality with adjustment for comorbid conditions. Kidney Int 1994; 45:1163-9.
5. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6:177-83.
6. Keshaviah PR, Ma J, Thorpe K, Churchill DN, Collins A. A comparison of 2 year survival on hemodialysis and peritoneal dialysis with a dose of dialysis matched using the peak concentration hypothesis. J Am Soc Nephrol 1995; 6:540A.
7. Goeree R, Manalich J, Grootendorst P, Beecroft ML, Churchill DN. Cost analysis of dialysis treatments for end-stage renal disease (ESRD). Clin Invest Med 1995; 18:455-64.
8. Mendelssohn DC, for the CSN Professional and Public Policy Committee. Principles of end stage renal disease care. Ann R Coll Surg Can 1997; 30:271-3.
9. Mendelssohn DC, Chery A, for the Toronto Region Dialysis Committee. Dialysis utilization in the Toronto region from 1981 to 1992. Can Med Assoc J 1994; 150:1099-105.
10. Kjellstrand C, Moody H. Hemodialysis in Canada: a first class medical crisis. Can Med Assoc J 1994; 150:1067-71.
11. Desmeules M, Schaubel D, Fenton SS, Mao Y. New and prevalent patients with end-stage renal disease in Canada. A portrait of the year 2000. ASAIO J 1995; 41:230-3.
12. Port FK. End-stage renal disease: magnitude of the problem, prognosis of future trends and possible solutions. Kidney Int Suppl 1995; 50:S3-S6.
13. Mattern WD, McGaghie W, Rigby RJ, Nissenson AR, Dunham C, Khayrallah MA. Selection of ESRD treatment: an international study. Am J Kidney Dis 1989; 13:457-64.
14. Prichard SS. Treatment modality selection in 150 consecutive patients starting ESRD therapy. Perit Dial Int 1996; 16:69-72.
15. Nissenson AR, Prichard SS, Cheng IKP. Non-medical factors that impact on ESRD modality selection. Kidney Int 1993; 43(Suppl 40):S120-7.
16. Canadian Organ Replacement Register. Annual Report 1997. Volume 1: Dialysis and renal transplantation. Ottawa: Canadian Institute for Health Information, 1997.
17. United States Renal Data System. USRDS 1997 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1997.
18. Canadian Organ Replacement Register. 1992 Ontario Report. Don Mills, ON: Canadian Institute for Health Information, 1994.
19. Florakas C, Wilson R, Toffelmire E, Goodwin M, Morton R. Differences in the treatment of male and female patients with end stage renal disease. Can Med Assoc J 1994; 151:1283-8.
20. Canada - USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1997; 7:198-207.
21. NKF-DOQI. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 1997; 30(Suppl 3):S67-136.